Troglitazone interferes with gemfibrozil's lipid-lowering action

Diabetes Care. 1998 Nov;21(11):2028-9. doi: 10.2337/diacare.21.11.2028a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Chromans / therapeutic use*
  • Diabetes Mellitus / drug therapy
  • Drug Interactions
  • Gemfibrozil / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypoglycemic Agents / therapeutic use*
  • Hypolipidemic Agents / therapeutic use*
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Retrospective Studies
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Transcription Factors / metabolism
  • Triglycerides / blood*
  • Troglitazone

Substances

  • Chromans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Thiazolidinediones
  • Transcription Factors
  • Triglycerides
  • Troglitazone
  • Gemfibrozil